Breadcrumb Home NeuroGap People NeuroGAP-Psychosis 1.0 (2016-2023) Principal Investigators Karestan Koenen Ó³»´«Ã½ Harvard T.H. Chan School of Public Health Dickens Akena Makerere University, Uganda Lukoye Atwoli Moi University, Kenya Symon Kariuki KEMRI-Wellcome, Kenya Charles Newton KEMRI-Wellcome, Kenya KEMRI-Wellcome, Kenya, KEMRI-Wellcome, Kenya, Dan Stein University of Cape Town, South Africa Solomon Teferra Addis Ababa University, Ethiopia Zuki Zingela Walter Sisulu University, South Africa Ó³»´«Ã½/Harvard program staff Anne Stevenson Program Director Rocky Stroud II Assistant Program Director Mark Baker Database Manager NeuroDev Principal Investigators Elise Robinson Ó³»´«Ã½ Amina Abubakar KEMRI-Wellcome, Kenya University of Cape Town, South Africa Charles Newton KEMRI-Wellcome, Kenya KEMRI-Wellcome, Kenya, KEMRI-Wellcome, Kenya, Research Director Dr. Celia van der Merwe Ó³»´«Ã½ GINGER Lori Chibnik Principal Investigator Ó³»´«Ã½ Harvard T.H. Chan School of Public Health Bizu Gelaye Associate Director Ó³»´«Ã½ Harvard T.H. Chan School of Public Health Kristianna Post Program Director Ó³»´«Ã½ Harvard T.H. Chan School of Public Health NeuroGenE (2017-2023) Principal Investigator University of Oxford, UK NeuroGap About GINGER Meet the Research Fellows 2020-2024 Cohort 2017-2019 Cohort NeuroDev NeuroGAP-Psychosis NeuroGenE People Latest news News 11.03.2025 Biology of Adversity Project launches at Ó³»´«Ã½ News 10.31.2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Ó³»´«Ã½ for chimeric antigen receptor (CAR) T-cell therapy News 10.31.2025 Genetic variant increases risk of heart muscle disease common in individuals of African ancestry News 10.16.2025 Ó³»´«Ã½-Bayer collaboration leads to drug candidate for a hard-to-treat type of lung cancer All news
News 10.31.2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Ó³»´«Ã½ for chimeric antigen receptor (CAR) T-cell therapy
News 10.31.2025 Genetic variant increases risk of heart muscle disease common in individuals of African ancestry
News 10.16.2025 Ó³»´«Ã½-Bayer collaboration leads to drug candidate for a hard-to-treat type of lung cancer